248 related articles for article (PubMed ID: 7073938)
1. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
2. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
3. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs.
Twentyman PR; Workman P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):611-3. PubMed ID: 7107382
[TBL] [Abstract][Full Text] [Related]
4. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
5. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
Workman P; Twentyman PR
Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization by lipophilic nitroimidazoles.
Twentyman PR; Workman P
Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
8. Chemopotentiation in vivo: no loss of sensitization with fractionation.
Hill SA; Siemann DW
Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
[TBL] [Abstract][Full Text] [Related]
9. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
10. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Twentyman PR
Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
[TBL] [Abstract][Full Text] [Related]
11. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
Urano M; Wong KH; Reynolds R; Begley J
Int J Hyperthermia; 1995; 11(3):379-88. PubMed ID: 7636324
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Lee FY; Workman P
Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
[TBL] [Abstract][Full Text] [Related]
13. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of combination chemotherapy by nitroheterocyclics.
Siemann DW; Allalunis-Turner MJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Hirst DG; Brown JM; Hazlehurst JL
Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
[TBL] [Abstract][Full Text] [Related]
16. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
17. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
Twentyman PR; Workman P
Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
[TBL] [Abstract][Full Text] [Related]
20. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Lee FY; Workman P
Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
